SK Bioscience, an innovative vaccine and biotech company dedicated to promoting human health from prevention to cure, has announced a development licensing agreement with Hilleman Laboratories, a vaccines and biologics research and development...
Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced that the US Food and Drug Administration has approved Silmitasertib (CX-4945)'s phase II...
Lupin Limited has announced that the United States Food and Drug Administration (US FDA) has approved its Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg, to market a generic equivalent of Kowa Company Limited's...
Merck, known as MSD outside the United States and Canada, and Caraway Therapeutics, Inc. announced a definitive agreement in which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to...
Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on combining traditional therapeutics with psychedelic research, announced a new exclusive license agreement with medical technology manufacturer Medspray Pharma BV for its...
Lupin stated that its abbreviated new drug application for Dapagliflozin Tablets has gained preliminary clearance from the US Food and Drug Administration. The medications are prescribed to patients with type 2 diabetes. The company said that the...
With the release of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition), the World Health Organization (WHO) is furthering the worldwide fight against acute malnutrition in children under the...
Torrent Pharma, a Rs. 9,400 crore plus pharma company, reported a robust financial performance in the second quarter ending September 2023, despite decreasing revenues in the United States. Its consolidated net profit climbed by 23.7% to Rs. 386...
Roche announced the debut of the LightCycler PRO System, which is based on the established gold standard technology of previous LightCycler Systems. This innovative technology improves performance and usability while bridging the gap between...
Owl Therapeutics, a fully owned subsidiary of Gryphon Bio, announced a global license and partnership agreement with Lund, Sweden-based Abliva AB to advance Abliva's NeuroSTAT (OWL-1410) for the prevention and treatment of moderate to severe...